Liver disease

Resources (which contain promotional information) provided by Norgine.
View TARGAXAN ® (rifaximin-α) prescribing and adverse events reporting information
UK-HEP-XIF-2100027 Date of preparation: October 2021
  • Best practice in hepatic encephalopathy

  • Consensus statement: identification and management of hepatic encephalopathy

Educational resources

Dr Richard Aspinall-sponsored symposium: an algorithm approach to showcasing management of hepatic encephalopathy from secondary to primary care

Sponsored symposium: An Algorithm approach to Showcasing Management of Hepatic Encephalopathy from Secondary to Primary Care – Dr Richard Aspinall

Commissioned by Norgine Pharmaceuticals Limited

This video has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines Live.
View TARGAXAN® (rifaximin-α) adverse event reporting and prescribing information
UK-HEP-XIF-2200002 | March 2022

Decompensated cirrhosis animation image

Animation on the decompensated cirrhosis care bundle—the first 24 hours

Commissioned by Norgine Pharmaceuticals Limited

This animation has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines in Practice.
UKE-COR-NP-2100080  Date of preparation: October 2021